NCT01989559View on ClinicalTrials.gov

Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin MelanomaStage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin MelanomaStage IV Skin Melanoma
Interventions
BIOLOGICAL

gp100:209-217(210M) Peptide Vaccine

Given SC

BIOLOGICAL

HPV 16 E7:12-20 Peptide Vaccine

Given SC

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

97213

Providence Portland Medical Center, Portland

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01989559 - Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery | Biotech Hunter | Biotech Hunter